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Introduction
Pancreatic cancer is one of the leading causes of death in
the USA. Mortality rates place this neoplasm fourth as far
as morbidity is concerned [1, 2]. Prognosis is very poor,
with the one-year mortality rate exceeding 80% and the
overall 5-year survival rates not exceeding 5%. Detection
of early pancreatic cancer is of great importance because
this type of carcinoma is potentially resectable. However,
early detection is extremely difficult due to the scarcity of
symptoms.
The choice of treatment in pancreatic cancer de-
pends mostly on correct diagnosis and staging. Accurate
diagnosis enables the most appropriate method of surgical
and multimodal treatment and avoids unnecessary
laparotomy (which in advanced disease does not improve
survival nor quality of life and exposes patients to
increased suffering at the same time generating high
treatment costs).
Endoscopy, computed tomography, MRI and ultra-
sonography are the most common methods used to today
in order to evaluate pancreatic carcinoma. Computed
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A i m.  to assess the clinical value of endoscopic ultrasound in the staging of pancreatic carcinoma as opposed to
ultrasonography and CT.
M a t e r i a l  a n d  m e t h o d s.  We evaluated 42 patients (18 F, 24 M; mean age 61.3) operated on for pancreatic carcinoma
between 1991 and 2002 analysing accuracy, sensitivity, specificity, PPV and NPV of routine and doppler ultrasonography, CT
and EUS.
R e s u l t s.  EUS showed the best accuracy in local tumour staging – 93.1%, vascular infiltration – 90%, and lymph node
assessment – 87.5%. Routine USG was the least accurate: 82.5%, 67.5% and 72.5%, respectively. The accuracy of both CT
and doppler USG were similar: 88.1%, 82.5% and 80.0%.
C o n c l u s i o n s.  EUS is the most accurate method available to stage pancreatic cancer in the pre-operative period. However,
the advantage of EUS as opposed to CT and USG does not justify its routine use due to the costs, its low availability and
invasiveness.
WartoÊç kliniczna badaƒ obrazowych (USG, EUS, KT)
w ocenie zaawansowania raka trzustki
C e l  p r a c y.  Ocean wartoÊci klinicznej ultrasonografii endoskopowej w ocenie zaawansowania raka trzustki jako metody
konkurencyjnej dla USG i tomografii komputerowej.
M a t e r i a ∏  i m e t o d y.  Badaniu poddano 42 chorych (18 K, 24 M), Êredni wiek: 61,3) operowanych z powodu raka
trzustki w latach 1991–2002. Przeanalizowano trafnoÊç diagnostycznà, czu∏oÊç, swoistoÊç, PPV i NPV USG tradycyjnego,
doplerowskiego, KT i EUS.
W y n i k i.  Najwy˝szà dok∏adnoÊç w ocenie zaawansowania miejscowego, naciekania naczyƒ krwionoÊnych oraz przerzutów
do w´z∏ów wykaza∏a EUS – odpowiednio 93,1%, 90%, 87,5%. Najmniejszà trafnoÊç wykaza∏o rutynowe badanie USG:
odpowiednio 82,5%, 67,5% i 72,5%. TrafnoÊç KT i doplerowskiego USG by∏a zbli˝ona: 88,1%, 82,5% oraz 80,0%.
W n i o s k i.  Najbardziej precyzyjnà metodà w przedoperacyjnej ocenie miejscowego zaawansowania raka trzustki jest
endoskopowa ultrasonografia. Wydaje si´ jednak, ˝e z powodu kosztu, ma∏ej dost´pnoÊci i inwazyjnoÊci nie mo˝e ona
zastàpiç w rutynowej diagnostyce raka trzustki metod ultrasonograficznych i tomografii komputerowej.
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tomography, considered to be the "gold standard" in many
countries, achieves a 95% accuracy in detecting and
staging pancreatic carcinoma. Routine ultrasonographic
techniques are slightly less efficient, with an accuracy
ranging from 67% to 85% [3-5]. Some authors report
that Doppler imaging can improve those results, even up
to 95% [3, 6, 7].
EUS is an imaging technique, which combines both
endoscopy and ultrasonography, and thus possesses
advantages of both modalities (exclusion of acoustic
barriers and higher picture resolution). It is thought that
EUS is one of the best methods for detecting small, early
pancreatic neoplasm [8-10].
The aim of the study was to assess the clinical value
of endoscopic ultrasound in detecting and staging
pancreatic carcinoma compared to more routine imaging
methods.
Material and methods
The study was designed as a retrospective clinical trial involving
42 patients (18 women and 24 men; mean age 61.3; range 37-81
years) operated on for pancreatic tumour (with suspicion of
carcinoma) at the 1st Department of General and GI Surgery,
Jagiellonian University of Cracow, between January 1991 and
December 2002. All subjects gave informed consent.
Using routine color and power Doppler ultrasonography,
helical computed tomography and EUS, multiple analyses of
diagnostic accuracy, sensitivity, specificity, and positive as well as
negative prognostic values (PPV and NPV) were made. The
stage of the cancer was consistently classified using WHO TNM
classification. Siemens Sonoline AC and Hitachi EUB 555 and
6000. Ultrasonographic equipment was used to perform ultra-
sound examinations. Helical, dual-scan computed tomography
was performed using Elscint and Siemens Sommatom Sensation
10 approx. three hours after the administration of oral contrast
(1000 ml 2.0% Urographin, Schering AG) and additional
administration of intravenous contrast (Uropolinum or Omi-
paque, Polpharma and Nycomed, respectively). Endoscopic
ultrasound examinations were made using Pentax FG-38UX
and Olympus EXU-M3 with Siemens Sonoline AC and Hitachi
EUB 555 and 6000. Examinations were performed in the lateral
position, after infusion of pharmaceutical pre-medication
(Dolargan and Buscolisinum i.v.). All results were collected as
prints, *.jpeg, *.tiff files (MO and HD).
All examinations were performed according to the same
protocol, which included the evaluation of pancreatic neoplasm,
its local and regional staging, as well as the assessment of all
other abdominal organs, in order to determine the presence of
dissemination and distant metastases. To verify the accuracy of
diagnostic imaging, the following methods were used:
– intraoperative surgeon’s evaluation,
– histopathological examination of the tumor and specimens,
– intraoperative ultrasound findings.
Statistical evaluation was performed using StatisticaTM
software. Student's T test was used to determine significant
differences.
Results
The study included 42 patients, 27 of which underwent
pancreatic resection (11 Kausch-Whipple procedures,
9 pylorus-preserving resections, 4 total pancreatectomies,
and 3 distal resections). Only 15 palliative procedures
(due to unresectable cancer) were performed.
In 37 of 42 patients who underwent surgery, the
diagnosis of pancreatic ductal carcinoma was made. In 3
patients, endocrine neoplasm (insulinoma) was found
and in 2 patients – non-cancerous lesions (chronic
pancreatitis) were diagnosed. The most common, local
stage of cancer according to the TNM classification was
T4, found in 11 patients (29.7%). Less frequent stages
were T2 and T3, found in 10 patients (27.0%) and 9
patients (24.3%), respectively. The least common stage
diagnosed was early carcinoma, T1, detected in 7 patients
(18.9%). Complete analysis of diagnostic accuracy of
EUS, CT and ultrasonographic methods was carried out
in 37 patients with pancreatic ductal adenocarcinoma;
the other cases (endocrine and non-carcinomatous
tumours) were omitted from study.
Although full statistical analysis was not possible in
the group with T1 stage cancer, due to small group size
(n=7), it is worth mentioning that the most accurate
modality to assess early cancer was EUS (6 correct
diagnoses and 1 false negative). There were 4 false
negative results with routine USG and 3 false negatives
with CT and doppler-USG combined. Detailed data is
shown in Table I.
Table I. Overall accuracy of ultrasonographic modalities, EUS and CT
in local staging of pancreatic cancer (n=37)
Routine NS/S Doppler NS/S EUS NS/S CT
USG USG
T1 (n=7)
Correct diagnosis 3/7 4/7 6/7 4/7
T2 (n=10)
Accuracy 77.5 S 85.0 S 92.5 S 85.0
T3 (n=9)
Accuracy 77.5 S 85.0 S 90.0 S 85.0
T4 (n=11)
Accuracy 85.0 S 90.0 S 92.5 S 90.0
Statistical analyses of T2-T4 stages were made
separately with a combined T1-T4 stage analysis. The
most accurate assessment of T2 stage was made with EUS
(overall accuracy 92.5%), and the sensitivity, specificity,
PPV and NPV are all presented together with the
parameters of the other methods in Table I. The accuracy
of routine ultrasound, Doppler ultrasound and CT were
77.5% and 85.0%, respectively.
EUS was also determined to be the best method
used to assess T3 and T4 stages (90.0% and 92.5%,
respectively). The difference between EUS and the other
imaging tests used was significant (p<0.05). Routine USG
used to assess stages T3 and T4 achieved accuracy scores
of only 77.5% and 85.0%, respectively; but both doppler-
USG and CT improved the results to 85.0% and 90.0%
accuracy, respectively [Figures 1-4].
General analysis of local advancement of pancreatic
carcinoma (stages T1 – T4) proved that EUS was the
most efficient method, with a diagnostic accuracy of
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93.1% and a sensitivity, specificity, PPV and NPV of
82.5%, 96.6%, 89.1% and 95.1%, respectively. These
results were significantly better than the other methods,
all of which are shown in Table I.
The evaluation of ultrasound and CT techniques to
assess vascular carcinomatous infiltration was the next
aim of the study. Such data is essential when planning
surgery. Each ultrasound and CT exam included the
evaluation of the following vessels: the superior mesen-
teric vein and artery, the portal vein, the inferior vena
cava, the aorta and the celiac trunk [Figures 5, 6].
Routine ultrasound procedure achieved a relatively
low accuracy of 67.5% (sensitivity: 74.0%, specificity:
53.8%, PPV: 76.9% and NPV: 53.8%) and color-doppler
imaging improved the accuracy up to 82.5% (sensitivity,
specificity, PPV and NPV 88.8%, 69.2%, 85.7% and
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Figure 1. Pancreatic cancer – EUS
Figure 2. Pancreatic cancer – EUS + Doppler technique – no signs of
vessel infiltration
Figure 3. Advanced pancreatic cancer (T 4) – EUS
Figure 4. Pancreatic cancer: USG – color-Doppler – no infiltration of
large vessels
Figure 5. Pancreatic cancer: USG – power-Doppler – infiltration of the
portal vein
Figure 6. Pancreatic cancer – EUS + Doppler technique – portal vein
infiltration
75.0%, respectively). The same results were obtained with
CT. EUS was the most accurate method with an overall
rate 90.0%, and sensitivity, specificity, PPV and NPV of
96.1%, 84.6%, 92.0%, and 84.6%, respectively. These
results were significantly higher than the other obtained.
The presence of nodal spread of pancreatic carci-
noma is very valuable information from the surgeons’
point of view, as it is always associated with a poor
prognosis. In this study the accuracy of imaging methods
was evaluated in a group of 40 patients (only the patients
who underwent resection were enrolled). Histopatho-
logical examinations showed the incidence of nodal
metastases to be 16 (40%).
The study showed that EUS is the most precise
diagnostic tool to determine lymph node metastases; EUS
accuracy reached 87.5%, while the efficacy of routine
ultrasound was 72.5%, ultrasound with doppler technique
80.0% and CT 82.5%. The differences were significant
(p<0.05).
Discussion
Modern approach to pancreatic cancer treatment requires
individual strategy and is mostly depended on diagnostic
tools, as correct diagnosis and staging determine further
tactics. Although endoscopy, computed tomography, MRI
and ultrasound are most often used to evaluate pancreatic
carcinoma, there is still a need to find the most optimal
diagnostic method for its staging.
Correct assessment of early pancreatic carcinoma
(T1 stage according to WHO) proves most valuable in
pre-operative diagnosis. Innocenti et al. and Pichler et
al. have reported that the accuracy of routine ultra-
sonography in T1 evaluation does not exceed 67.0% –
72.3%, and Doppler technique increases it to 87.4% [11,
12]. The accuracy of CT, according to Freeny et al., Gress
et al. and Legman et al., reaches 67.0% [13-15]. Rosch et
al. and Shoup et al. showed accuracy of 90.0% – 99.0% in
early pancreatic cancer staging with EUS, documenting its
value in detecting endocrine tumors smaller than 15
millimeters in diameter [15, 16]. The same high efficacy
was observed in advanced stages: Mertz et al., Rosch et al.
and Shoup et al. reported an accuracy of 93.0% – 100% in
stages T2 – T4 [15-17].
The efficiency of imaging methods in advanced
cancer stages is far better than in other methods;
according to Pichler et al. and Howard et al., the accuracy
of routine ultrasound at stages T2 – T4 was 85.0% –
90.0%, while Doppler technique increased it to 91.2%
[12, 18]. At the same stage, CT showed an efficacy of
95.0%, reported by Bluemke, Calculli, Legman and Rosch
et al. This opinion was, however, questioned by Chen et
al. and Gorelick et al [3, 5, 15, 19, 20, 21].
Our research confirmed that EUS plays a leading
role in local staging assessment. In the early stage, we
observed only one false negative result out of seven cases.
Accuracy of 92.5%, 90.0 and 92.5% was observed in
stages T2, T3 and T4, respectively. The efficiency of
routine and Doppler ultrasound and CT was poorer.
The presence of large vessel involvement caused by
pancreatic cancer is important information when planning
surgery. The efficiency of routine ultrasound for deter-
mining local vascular invasion is variable and can be poor.
A majority of authors judge it to be about 60.0% [1, 8].
Modern ultrasound techniques improve the accuracy,
increasing it to even 84.0% – 96.0% [6, 22, 23]. According
to Calculli et al., Legman et al. and Ueno et al., CT is
considered to be of similar effectiveness, reaching up to
100%, while others report values higher than 80.0% to be
unlikely [3, 5, 14, 20, 22, 24].
Opinions vary as to the accuracy of EUS; Baarir et
al. have shown it to be 95.0 %– 96.0%, but Howard et
al. have questioned these outcomes, reporting the
accuracy to be 76.0% [18, 25].
In our study the accuracy of routine ultrasound was
67.5%. 82.5% accuracy was achieved with Doppler-
ultrasound and computed tomography combined. EUS
was the best method to evaluate vascular involvement,
with a correct diagnosis in 90.0% of cases. Our research
concurred with the majority of reports regarding EUS,
however, the accuracy of CT was lower than that reported
by Calculli, Legman and Ueno [3, 5, 23].
The evaluation of nodal spread, which is an im-
portant prognostic factor, is one of the most difficult tasks
to assess. Gorelick et al. and Pichler et al. have reported
routine ultrasound to have an accuracy of 76.6% – 78.3%,
but Chen et al. have questioned this opinion, because in
their study sensitivity did not exceed 33% [12, 20, 21].
Both Bunk et al. and Innocenti et al. indicate that
Doppler techniques can improve the efficacy, increasing it
to 82.5% [11, 22]. CT, which is thought to be the ”gold
standard” in local assessment of pancreatic cancer, is also
helpful in nodal status evaluation. Chen et al., Grees et
al., Legman et al., van Hoe et al. and Tomazic et al.
demonstrated its accuracy to be 50.0% – 85.0% with CT,
which was not confirmed by Chen et al. and Yeo et al.
(accuracy of 50.0%) [5, 7, 20, 26, 27]. The efficiency of
EUS is also variable; Howard et al., and Gress et al.
observed an accuracy of 72.0% – 75.0%, while Chen et al.,
and Yeo et al. reported only 47.0% – 62.0% [14, 18, 20,
27].
Our results have confirmed the relatively low
accuracy of routine ultrasonography (72.5%), doppler-
ultrasonography (80.0%) and CT (82.5%). Again, EUS
proved to be the most efficient, with an accuracy
exceeding 87.0%.
Our study demonstrated that endoscopic ultra-
sonography is the most accurate method of assessing not
only local tumor stage, but also vascular and nodal status.
The efficiency of EUS was the highest in all categories,
but only in the case of early carcinoma did the difference
achieve statistical significance. In the other categories
this difference was not so obvious. Thus EUS is an
expensive, invasive technique with a low availability and
creating the possible need to re-examine the patient.
Therefore, it should not be the routine method of choice
in each case, but should be used only when the diagnostic
problems cannot be solved with ultrasound or CT.
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Conclusions
1. EUS is the best method to diagnose early pancreatic
cancer (6 out of 7 patients); the same diagnosis was
made in only 3 and 4 of these same 7 cases when USG
or CT were used, respectively.
2. The general local staging accuracy of EUS exceeded
93.1%, routine ultrasound reached 82.5%, and
Doppler USG and CT reached 88.1%.
3. The accuracy of vascular involvement detection was
67.5% with routine USG, 82.5% with CT and Doppler
USG, and 90.0% with EUS.
4. The accuracy of EUS is also the highest in lymph node
assessment (87.5%).
5. Endoscopic ultrasonography is the most accurate
method to diagnose and stage pancreatic carcinoma
in the pre-operative period.
6. EUS is invasive, expensive and of limited availability as
compared to routine or Doppler USG; therefore, it
should be used in selected cases, especially when early
pancreatic carcinoma is suspected.
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